Clinical Trials Browser

BF-200 ALA × Clear all

NCT05662202 2026-02-19

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Phase 3 Active not recruiting

Keratosis, Actinic

NCT05060237 2024-10-17

Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

Phase 1 Completed

112 enrolled 21 charts

DermatologicOther neoplasm

Keratosis, Precancerous Conditions, Skin Diseases, Keratosis, Actinic

NCT04319159 2021-11-11

Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK)

Phase 1 Completed

48 enrolled 27 charts

Keratosis, Actinic

NCT02367547 2019-03-28

Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL

Phase 1/2 Unknown

Carcinoma, Basal Cell, Neoplasms, Basal Cell

NCT02685592 2018-05-30

LM PDT

Phase 4 Completed

Hutchinson's Melanotic Freckle

NCT02799069 2017-04-28

Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy

Phase 3 Completed

571 enrolled 46 charts

Keratosis, Actinic